Susan N. Chi , MD
|
Director, Pediatric Brain Tumor Clinical Trials Program
Office Phone: 617-632-4386
Appointment Line: 1-888-PEDI-ONC (733-4662)
Fax: 617-632-4897
NPI: 1154398964 |
Departments/Divisions
Specialties
atypical teratoid rhabdoid tumor (ATRT)
hematology/oncology
neuro-oncology
Services/Programs
Academic Appointments
Assistant Professor in Pediatrics, Harvard Medical School
Certifications
Pediatrics, Pediatric Hematology/Oncology
College
Princeton University, Princeton, NJ
(1986-1990)
Medical School
Mount Sinai School of Medicine, New York, NY
(1990-1994)
Residency
Pediatrics, Yale New Haven Children's Hospital, New Haven, CT
(1994-1998)
Fellowships
Memorial Sloan Kettering Cancer Center, New York, NY
(1998-2001)
New York University Medical Center , New York, NY
(2001-2002)
Publications
Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C and Kieran MW
, 2005
Issue: 72
, Page: 77-84
J Neuro-oncol
Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW
, 2009
Issue: 27
, Page: 385-389
J Clin Oncol
Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Friedman HS, Packer RJ, Rood BN, Boyett JM, Kun LE
, 2010
Issue: 28
, Page: 3069-75
J Clin Oncol
Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JF
, 2004
Issue: 22
, Page: 4881-7
J Clin Oncol
Brain Tumors
- Chemotherapy of medulloblastoma (J Clin Oncol 22:4881, 2004)
- Complications of therapy (Pediatr Neurol 35:122, 2006)
- Prognostic Value of Tumor Microinvasion and Metalloproteinases Expression in Intracranial Pediatric Ependymomas. J Neuropathol Exp Neurol. 2008 Sept;67(9):911-20.
- Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007 Mar 20;68(12):932-8.
- Transverse myelitis after therapy for primitive neuroectodermal tumors. Pediatr Neurol. 2006 Aug;35(2):122-5.
- Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer. 2007 Jul;49(1):34-40.
-
Dana-Farber Cancer InstituteDepartment of Pediatric Oncology450 Brookline AveBoston, MA 02215Phone: 617-632-4386Fax: 617-632-4897